Optas LLC’s Gilead Sciences GILD Stock Holding History

Optas LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Sell	3,803 -323	-8%	-$42.6K	0.07%	191
2026 Q1	$575K	Buy	4,126 +351	+9%	+$49.2K	0.09%	146
2025 Q4	$463K	Buy	3,775 +198	+6%	+$24.1K	0.07%	189
2025 Q3	$397K	Buy	3,577 +130	+4%	+$14.8K	0.07%	199
2025 Q2	$382K	Buy	3,447 +503	+17%	+$53.5K	0.07%	176
2025 Q1	$330K	Buy	2,944 +347	+13%	+$35.8K	0.06%	186
2024 Q4	$240K	Buy	+2,597	New	+$234K	0.05%	217
2020 Q4	–	Sell	-3,468	Closed	-$220K	–	154
2020 Q3	$220K	Buy	+3,468	New	+$240K	0.07%	145
2020 Q2	–	Sell	-3,914	Closed	-$294K	–	139
2020 Q1	$294K	Sell	3,914 -9,988	-72%	-$690K	0.15%	91
2019 Q4	$903K	Buy	+13,902	New	+$905K	0.35%	45

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Optas LLC's GILD Position: Q2 2026 in Review

Optas LLC reduced its Gilead Sciences (GILD) stake by 7.8% in Q2 2026, selling an estimated $42.6K and leaving 3,803 shares worth $480K. The position accounts for 0.07% of the portfolio, ranked #191.

Optas LLC first reported a position in GILD in Q4 2019 and has held it in 10 quarters since. The position peaked at $903K in Q4 2019. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Optas LLC held 3,803 shares of Gilead Sciences worth $480K as of Q2 2026.
Optas LLC sold 323 Gilead Sciences shares in Q2 2026, an estimated $42.6K.
Gilead Sciences made up 0.07% of Optas LLC's portfolio in Q2 2026, its #191 holding.
Optas LLC first reported a position in Gilead Sciences in Q4 2019 and has held it in 10 quarters since.
Optas LLC's Gilead Sciences position peaked at $903K in Q4 2019.
610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.